Literature DB >> 31500486

Novel surgical technique and efficacy analysis of donor pancreas preparation without vascular reconstruction in pancreas transplantation.

Wen-Wei Liao1, Xiang-Chao Ling1, Cheng Zhang1, Fu-Rong Liu2, Xiao-Feng Zhu1, Xiao-Shun He1, An-Bin Hu1.   

Abstract

Entities:  

Keywords:  Donor pancreas; efficacy analysis; pancreas transplantation; preparation; surgical technique; vascular reconstruction

Mesh:

Year:  2019        PMID: 31500486      PMCID: PMC7045680          DOI: 10.1177/0300060519870894

Source DB:  PubMed          Journal:  J Int Med Res        ISSN: 0300-0605            Impact factor:   1.671


× No keyword cloud information.

Introduction

Pancreas transplantation, particularly simultaneous pancreas–kidney transplantation, has become a radical treatment for patients with type 1 diabetes mellitus (T1DM), patients with T1DM with end-stage renal disease, and some patients with type 2 diabetes mellitus (T2DM).[1-4] As of 2014, approximately 40,000 cases of pancreas transplantation had been performed worldwide, with an average of 900 cases per year. The recipient and graft survival rates have continually improved, with an overall 5-year survival rate of 90%.[5,6] Considering the substantial number of patients with DM in the general population, the number of transplant cases and the graft survival rate are considerably lower than those for kidney or liver transplantation. Possible reasons for these differences include concerns about higher surgical risk in pancreas transplantation and the availability of the procedure, which is limited to a few domestic and foreign transplant centers. After pancreas transplantation, vascular complications such as thrombosis and hemorrhage are mainly responsible for pancreatic graft failure.[7-9] At most pancreas transplantation centers, the donor pancreas is procured only with the splenic artery and the superior mesenteric artery. The celiac trunk is preserved for the donor liver. Thus, the pancreas transplant must be prepared ex situ before transplantation with a Y-graft between the splenic artery and superior mesenteric artery using the donor’s external, internal, or common iliac artery.4 In China, en bloc removal of the pancreas and liver is a common practice and is followed by ex situ separation of the donor pancreas from the donor liver. The celiac trunk, superior mesenteric artery, and partial abdominal aorta from which these two arteries arise are preserved for the donor pancreas, and the common hepatic artery is preserved for the donor liver. Anastomosis of the proximal hepatic artery to the distal gastroduodenal artery is performed to reconstruct the arterial arch of the pancreatic head. In terms of vein management, the donor’s common iliac vein is anastomosed to the portal vein preserved in the donor pancreas to lengthen the pancreatic vein outflow channel and facilitate surgery in the recipient. These vascular anastomoses and reconstructions not only prolong the duration of pancreas preparation but inevitably increase the incidence of postoperative vascular complications because of the increased number of vascular anastomoses. To reduce the vascular complication rate and improve the comprehensive efficacy of pancreas transplantation, we modified the vascular preparation of the donor pancreas based on the experiences in domestic and international transplantation centers; i.e., no vascular reconstruction was performed. This novel procedure can theoretically reduce the incidence of vascular complications caused by thrombosis, hemorrhage, and prolonged cold ischemia.

Materials and methods

Recipient data

All recipients in this study were diagnosed with DM complicated with renal failure and scheduled to undergo simultaneous pancreas–kidney transplantation. All patients received insulin treatment to control their blood glucose levels and presented with varying degrees of DM-related complications. The detailed patient data are shown in Table 1.
Table 1.

Preoperative characteristics of recipients undergoing simultaneous pancreas–kidney transplantation.

Patient numberAge (years)SexDiabetes typeMajor comorbiditiesHemoglobin level (g/L)Albumin level (g/L)Blood glucose level (mmol/L)Creatinine level (µmol/L)Fasting C-peptide level (mmol/L)Blood insulin level (mmol/L)
160MaleIIRenal failureRetinopathy12338.24.46680.39936.7
227MaleIRenal failureRetinopathy8329.59.56560.0035.50
349MaleIIRenal failure8025.45.213384.01027.94
440FemaleIRenal failure8336.09.03020.0793.65
544MaleIIRenal failureRetinopathy10332.312.43900.75844.80
648MaleIIRenal failure11542.77.75630.01522.10
730MaleIRenal failure9234.97.75830.3125.80
848MaleIIRenal failure11638.65.111803.9926.30
941FemaleIIRenal failure9135.56.28560.51319.80
1054MaleIIRenal failure10533.67.15780.08733.60
1156MaleIIRenal failureRetinopathy9828.46.86800.62928.60
1247MaleIIRenal failure8837.14.75910.03721.70
Preoperative characteristics of recipients undergoing simultaneous pancreas–kidney transplantation.

Donor data

None of the donors had a history of DM or hyperglycemia before donation. The organ donation procedure was performed in accordance with the “Chinese Guidance of Donation after Cardiac Death.” All donor donations were performed after circulatory death.[10] The organs were procured via the rapid procure approach for abdominal organs (5 minutes after cardiac death). The detailed data of the donors are shown in Table 2.
Table 2.

Characteristics of donors for simultaneous pancreas–kidney transplantation.

Donor No.SexAge (years)Cause of deathPathogenic examinationLiver and kidney functionBlood sugar level (mmol/L)Weight, height, BMI (kg, cm, kg/m2)Presence of low blood pressure and low blood oxygenApplication of ventilator
1Male19Brain trauma due to car accidentNegativeNormal5.0770, 180, 20NoneYes
2Male42Extremely severe craniocerebral traumaNegativenormal5.6960, 168, 21NoneYes
3Male21Brain trauma due to car accidentNegativeNormal6.0055, 173, 19NoneYes
4Male27Extremely severe craniocerebral traumaNegativeNormal5.3470, 170, 24NoneYes
5Male8Ganglion neuroblastomaNegativeNormal9.0028, 120, 19NoneYes
6Male19Brain injury due to gunshot Cerebral herniaPositive sputum smearNormal15.5650, 168, 18NoneYes
7Male25Spontaneous intracerebral hemorrhageNegativeNormal5.6960, 168, 21Presence of low blood pressure/no hypoxiaYes
8Male22Severe craniocerebral traumaNegativeNormal6.8066, 174, 22NoneYes
9Female16Brain trauma due to car accidentNegativeNormal5.8040, 150, 17NoneYes
10Female26CO poisoningNegativeNormal5.9563, 168, 22NoneYes
11Male50Severe craniocerebral traumaNegativeNormal7.6271, 176, 24NoneYes
12Female25Brain trauma due to car accidentNegativeNormal3.8946, 162, 18NoneYes

BMI, body mass index; CO, carbon monoxide.

Characteristics of donors for simultaneous pancreas–kidney transplantation. BMI, body mass index; CO, carbon monoxide.

Donor pancreas procure

The en bloc removal technique for multiple abdominal organs was used to procure the donor pancreas. Ex situ separation of the donor pancreas from the donor liver was performed on the organ preparation table. The hepatoduodenal ligament was dissected. The common bile duct was excised close to the duodenum. The portal vein was transected in the middle of the hepatoduodenal ligament. The common hepatic artery and the gastroduodenal artery were transected at a site 0.5 cm from the bifurcation after separation. The bifurcated portion was preserved for the donor liver. The stumps of the preserved common hepatic artery and the gastroduodenal artery in the donor pancreas were marked with 6-0 Prolene sutures. At this point, the pancreas was separated from the liver.

Preparation of donor pancreas

For artery preparation, the patch was preserved simultaneously with the celiac trunk and superior mesenteric artery. Heparin saline was injected into the superior mesenteric artery, and an overflow sign from the stump of the gastroduodenal artery (which was excised during separation from the liver) indicated that the arterial arch of the pancreatic head was intact. Anastomosis was not required; the stumps of the gastroduodenal artery and common hepatic artery only needed to be ligated. The Carrel patch served as the inflow artery; a Y-graft was not required. For vein preparation, the portal vein was transected in the middle of the hepatoduodenal ligament to ensure a sufficient length of the anastomosis in the recipient, as previously described; lengthening of the portal vein was not required. At this point, pancreas preparation without ex situ blood vessel anastomosis was completed (Figure 1(a) and (b)).
Figure 1.

(a) Diagram and (b) photograph of pancreas preparation.

(a) Diagram and (b) photograph of pancreas preparation.

Surgical procedure in recipients

A para-rectus abdominis incision was made in the right lower abdomen to mobilize the external iliac artery and vein. The prepared donor pancreas was longitudinally placed in the right iliac fossa within the abdominal cavity, with the pancreatic head toward the head side. End-to-side anastomosis of the donor Carrel patch to the recipient’s external iliac artery was performed. The portal vein of the donor pancreas was anastomosed end-to-side to the recipient’s external iliac vein. A lateral incision was made in the side wall of the preserved duodenum in the donor pancreas, and leakage of pancreatic juice was observed. Side-to-side anastomosis of the donor duodenum and the recipient’s jejunum was performed to establish a channel for the pancreatic secretions (Figure 2(a)–(c)).
Figure 2.

Operative photographs of a pancreas transplant.

Operative photographs of a pancreas transplant.

Ethics statement

This study was approved by the Ethics Committee of the First Affiliated Hospital of Sun Yat-sen University (No. 2018-0096).

Results

The recipients comprised 12 patients (10 men and 2 women); 3 were primarily diagnosed with T1DM, and 9 were diagnosed with T2DM. Twelve donors were also included in the study. Pancreas preparation without vascular reconstruction was used in all 12 patients undergoing pancreas transplantation. Anastomosis of the donor portal vein and recipient external iliac vein was performed in the recipients; the donor Carrel patch was anastomosed to the external iliac artery of the recipient. The anastomosis procedure went smoothly. When the clamp was removed, the pancreatic blood inflow and outflow appeared normal. All 12 patients returned to consciousness 4 to 6 hours after the end of anesthesia. The patients were weaned from mechanical ventilation 8 to 14 hours after surgery. The patients stayed in the surgical intensive care unit for 2 to 3 days after surgery and were then transferred to the regular ward for routine rehabilitation. Flatus and defecation were reported 5 to 6 days after surgery. The serum C-reactive peptide levels returned to normal limits within 1 to 2 weeks, and the blood glucose and creatinine levels returned to normal limits within 2 to 3 weeks (Figure 3(a)–(c)). The transplanted pancreas functioned well in all recipients, and no vascular complications were reported.
Figure 3.

Early changes in the pancreas and renal function in patients undergoing pancreas transplantation.

Early changes in the pancreas and renal function in patients undergoing pancreas transplantation.

Discussion

Pancreas transplantation is an effective method for the treatment of end-stage DM.[11-13] The difficulty of pancreas transplantation is mainly due to the anatomical and physiological characteristics of the pancreas itself. The pancreatic blood supply and structure are complicated by the multiple blood vessels involved. Furthermore, the pancreatic tissues are fragile, easily damaged, and sensitive to ischemia. Therefore, pancreas procurement and preparation are keys to successful transplantation. A successful pancreas transplantation depends largely on the surgical techniques used.[14,15] Separation of the pancreas from the liver and performance of an isolated transplantation was historically considered impossible because the liver and pancreas share blood vessels.[16] The arterial blood supply of the pancreas mainly comes from three arteries: the superior mesenteric artery, the gastroduodenal artery, and the splenic artery. The pancreatic head is supplied by two arterial arches: (1) the anterior arterial arch, which includes the superior-anterior pancreaticoduodenal artery arising from the gastroduodenal artery and the inferior-anterior pancreaticoduodenal artery arising from the superior mesenteric artery, and (2) the posterior arterial arch, which includes the superior-posterior pancreaticoduodenal artery arising from the gastroduodenal artery and the inferior-posterior pancreaticoduodenal artery arising from the superior mesenteric artery. The two arterial arches supply the pancreatic head, the uncinate process, and the portion of the duodenum around the pancreatic head. The pancreatic body and tail are supplied by the splenic artery and its branches, especially the dorsal pancreatic artery and transverse pancreatic artery. Surgeons historically recommended preservation of the celiac trunk, splenic artery, and superior mesenteric artery for transplantation of the whole pancreas.[17] Separation and isolated transplantation of the liver and pancreas are relatively difficult because both transplants require use of the celiac trunk. In the late 1980s, these procedures became feasible after development of arterial reconstruction techniques.[18,19] In pancreas transplantation, arterial and venous reconstruction increases both the time required for pancreas preparation and the incidence of complications, including postoperative thrombosis, hemorrhage, pancreatic leakage, and intestinal leakage. A prolonged preparation time leads to a prolonged cold ischemia time, which causes corresponding complications such as pancreatic edema and pancreatitis. According to a study by Sutherland et al.,[20] the incidence of surgical complications in pancreatic transplantation ranges from 8% to 45%. A study by Harbell et al.[21] involving 112 patients undergoing pancreas transplantation with vascular reconstruction revealed postoperative thrombosis in 30 (27%) patients, graft loss in 5 patients, and venous thrombosis in 4 patients during the 5-year period following transplantation. Surgical complications often led to removal of the transplanted pancreas. To address these problems, the portal vein was transected in the middle of the hepatoduodenal ligament to ensure a sufficient length for transplantation. Lengthening of the portal vein was not necessary. In addition, heparin saline was injected into the superior mesenteric artery to test the integrity of the arterial arches of the pancreatic head. An overflow sign from the stump of the gastroduodenal artery indicated that anastomosis of the gastroduodenal artery and common hepatic artery was not required, but the stumps of the gastroduodenal artery and common hepatic artery needed to be ligated. The Carrel patch served as an inflow artery, and a Y-graft was not required.

Conclusions

The modified donor pancreas preparation without vascular anastomosis used in this study can significantly improve surgical efficiency. Theoretically, the omission of vascular anastomosis can greatly reduce the incidence of hemorrhage and thrombosis (no complications were reported in 12 patients in this study), promote patient recovery, and improve the comprehensive efficacy of pancreatic transplantation. However, the limitations of this study included its small sample size and short observation period. Thus, further studies are needed to improve pancreas transplantation.

Abbreviations

DM: diabetes mellitus. T1DM: type 1 diabetes mellitus. T2DM: type 2 diabetes mellitus.
  21 in total

1.  Combined hepatic and pancreaticoduodenal procurement for transplantation.

Authors:  C L Marsh; J D Perkins; D E Sutherland; R J Corry; S Sterioff
Journal:  Surg Gynecol Obstet       Date:  1989-03

2.  Procurement of a whole pancreas and liver from the same cadaveric donor.

Authors:  F L Delmonico; R L Jenkins; H Auchincloss; T J Etienne; P S Russell; A B Monaco; A B Cosimi
Journal:  Surgery       Date:  1989-06       Impact factor: 3.982

3.  Splenic Vein Thrombosis Following Pancreas Transplantation: Identification of Factors That Support Conservative Management.

Authors:  J W Harbell; T Morgan; V A Feldstein; G R Roll; A Posselt; S-M Kang; S Feng; R Hirose; C E Freise; P Stock
Journal:  Am J Transplant       Date:  2017-08-14       Impact factor: 8.086

Review 4.  Lessons learned from more than 1,000 pancreas transplants at a single institution.

Authors:  D E Sutherland; R W Gruessner; D L Dunn; A J Matas; A Humar; R Kandaswamy; S M Mauer; W R Kennedy; F C Goetz; R P Robertson; A C Gruessner; J S Najarian
Journal:  Ann Surg       Date:  2001-04       Impact factor: 12.969

Review 5.  Vascular complications of transplantation: part 2: pancreatic transplants.

Authors:  Minhaj S Khaja; Alan H Matsumoto; Wael E Saad
Journal:  Cardiovasc Intervent Radiol       Date:  2014-02-21       Impact factor: 2.740

Review 6.  New classification of donation after circulatory death donors definitions and terminology.

Authors:  Marie Thuong; Angel Ruiz; Patrick Evrard; Michael Kuiper; Catherine Boffa; Mohammed Z Akhtar; James Neuberger; Rutger Ploeg
Journal:  Transpl Int       Date:  2016-05-04       Impact factor: 3.782

7.  OPTN/SRTR 2016 Annual Data Report: Pancreas.

Authors:  R Kandaswamy; P G Stock; S K Gustafson; M A Skeans; M A Curry; M A Prentice; A Fox; A K Israni; J J Snyder; B L Kasiske
Journal:  Am J Transplant       Date:  2018-01       Impact factor: 8.086

Review 8.  The current challenges for pancreas transplantation for diabetes mellitus.

Authors:  Christopher J E Watson
Journal:  Pharmacol Res       Date:  2015-02-10       Impact factor: 7.658

9.  New surgical technique for pediatric en-bloc kidney and pancreas transplantation: the pancreas piggy-back.

Authors:  Matthias Waldner; Thomas Bächler; Erik Schadde; Marc Schiesser; Franz Immer; Pierre-Alain Clavien; Jens Gunther Brockmann
Journal:  Transpl Int       Date:  2012-10-16       Impact factor: 3.782

Review 10.  Pancreas transplantation: review.

Authors:  Roberto Ferreira Meirelles Júnior; Paolo Salvalaggio; Alvaro Pacheco-Silva
Journal:  Einstein (Sao Paulo)       Date:  2015 Apr-Jun
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.